Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187616 · ClinicalTrials.gov registry record
Questioning Patients About Adverse Medical Events
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 214
- Enrollment target
NCT00187616: Completed study, sponsored by University of California, San Francisco.
NCT00187616 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 214 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00187616 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 214 participants
- Enrollment target
Study Summary
This trial studies whether 3 different methods of asking patients about adverse medical events in a clinical trial affects the rate of reported side effects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2002-04 |
| Est. Completion | 2003-04 |
What the finished NCT00187616 record still lists
NCT00187616 is an observational study that tracks outcomes without assigning an intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00187616 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00187616 about?
NCT00187616 is a clinical study titled "Questioning Patients About Adverse Medical Events". This trial studies whether 3 different methods of asking patients about adverse medical events in a clinical trial affects the rate of reported side effects.
What is the current status of trial NCT00187616?
This trial is currently completed. The enrollment target is 214 participants. The study started on 2002-04. Estimated completion is 2003-04.
Who is sponsoring clinical trial NCT00187616?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia